Winning the 2008 NSW BioFirst Commercialisation award has come at exactly the right time for Special Phage Holdings, which has treated a patient in the clinic and is currently looking at a second round of private fundraising to develop its portfolio of bacteriophages

Unlisted Queensland biotech Xenome has reported good results in a Phase II trial of its candidate for chronic cancer pain relief and raised a good amount of cash to further its clinical development.

Western Australian company Orthocell is pioneering biological therapies to repair and regenerate damaged tendons and ligaments.

The Americans go to the polls in two months, and in the meantime many of the country’s regulatory agencies go into hibernation, including the all-important FDA.

A symposium at ComBio on wound healing promises to take audiences on a journey from basic cell biology right through to 3D skin scaffolds as therapies.

Australian-trained scientist Dr Paul Trainor has made a career of making faces. In doing so, he hopes to uncover novel ways to prevent or treat congenital birth defects.

Genera Biosystems is distributing its new HPV test through Gribbles Pathology and promises more in the booming molecular diagnostics field.

UK researchers find unsual levels of telomerase in cells of endometriosis sufferers

Australian medical device company Ventracor is so pleased with its clinical trial design, it’s decided to apply for a patent for it.

Fresh from his role as one of the head spruikers of Queensland biotech at BIO in San Diego and DIA in Boston, the CEO of the Queensland Clinical Trials Network, Mario Pennisi, is looking forward to hosting CRX08.

Australian researchers urge HIV-positive people on antiretrovirals to continue practising safe sex